1. 00070 A MULTICENTRE PHASE II TRIAL OF GEFITINIB 500 MG/ DAY IN PATIENTS WITH RECURRENT EGFR-POSITIVE GYNAECOLOGICAL TUMOURS. (1st September 2005) Authors: Vergote, I.; Amant, F.; Forget, F.; Canon, J. L.; Awada, A.; Dirix, L.; Van Belle, S. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2550 Phase Ib study of abiraterone acetate (AA) plus buparlisib (BKM120) or BEZ235 in patients (pts) with castration-resistant prostate cancer (CRPC). (September 2015) Authors: Chi, K.; Castellano, D.; De Bono, J.; Gravis, G.; Dirix, L.; Machiels, J.P.; Mita, A.; Mellado Gonzalez, B.; Massard, C.; Trandafir, L.; Dey, D.; Csonka, D.; Chakravartty, A.; Fizazi, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2575 Presence of androgen receptor splice variants in circulating tumor cells and response to cabazitaxel in castration-resistant prostate cancer. (September 2015) Authors: Onstenk, W.; Sieuwerts, A.; Kraan, J.; Van, M.; Nieuweboer, A.; Mathijssen, R.; Hamberg, P.; Meulenbeld, H.; DeLaere, B.; Dirix, L.; Van Soest, R.; Lolkema, M.; Martens, J.; Van Weerden, W.; Jenster, G.; Foekens, J.; De Wit, R.; Sleijfer, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer. (October 2020) Authors: Van Berckelaer, C.; Van Geyt, M.; Linders, S.; Rypens, C.; Trinh, X.B.; Tjalma, W.A.A.; Van Laere, S.; Colpaert, C.; Dirix, L.; van Dam, P.A. Journal: Breast Issue: Volume 53(2020) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Intraoperative sentinel node identification with Technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: A feasibility study. Issue 2 (1st February 2003) Authors: Van Dam, P. A.; Hauspy, J.; Vanderheyden, T.; Sonnemans, H.; Spasepen, A.; Eggenstein, G.; Dirix, L.; Verkinderen, L. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 2(2003) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study. (1st June 2020) Authors: Dummer, R.; Guminksi, A.; Gutzmer, R.; Lear, J.T.; Lewis, K.D.; Chang, A.L.S.; Combemale, P.; Dirix, L.; Kaatz, M.; Kudchadkar, R.; Loquai, C.; Plummer, R.; Schulze, H.‐J.; Stratigos, A.J.; Trefzer, U.; Squittieri, N.; Migden, M.R. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: 1369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study. (8th December 2019) Authors: Dummer, R.; Guminksi, A.; Gutzmer, R.; Lear, J.T.; Lewis, K.D.; Chang, A.L.S.; Combemale, P.; Dirix, L.; Kaatz, M.; Kudchadkar, R.; Loquai, C.; Plummer, R.; Schulze, H.‐J.; Stratigos, A.J.; Trefzer, U.; Squittieri, N.; Migden, M.R. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: 1369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study. (6th November 2017) Authors: Lear, J.T.; Migden, M.R.; Lewis, K.D.; Chang, A.L.S.; Guminski, A.; Gutzmer, R.; Dirix, L.; Combemale, P.; Stratigos, A.; Plummer, R.; Castro, H.; Yi, T.; Mone, M.; Zhou, J.; Trefzer, U.; Kaatz, M.; Loquai, C.; Kudchadkar, R.; Sellami, D.; Dummer, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 3(2018) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC-0452: Mature results of a phase I dose-escalation trial of SBRT for bone and lymph node oligometastases. (November 2020) Authors: Mercier, C.; Claessens, M.; De Kerf, G.; Gryshkevych, S.; Billiet, C.; Joye, I.; Buys, A.; Van Laere, S.; Vermeulen, P.; Meijnders, P.; Löfman, F.; Dirix, L.; Verellen, D.; Dirix, P. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-0765 Oncological and cosmetic outcome after IOERT as a boost in a large cohort of breast cancer patients. (April 2019) Authors: Machiels, M.; Weytjens, R.; Erven, K.; Westerhoff, J.M.; Amrouch, S.; Bosiers, J.; Verkinderen, L.; Hauspy, J.; Van Dam, P.; Dirix, P.; Vos, M.; Huget, P.; Dirix, L.; Meijnders, P.; Van Laere, S.; Vermeulen, P.B.; Billiet, C. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗